News

Director Amy B. Lane sold 950 shares of TJX Companies stock worth about $121,685, trimming her stake by 4.01%. Despite the ...
Steigerwald Gordon & Koch Inc. trimmed its Deere & Company holdings by 2.5% in Q1, offloading 1,393 shares. Despite the ...
NBC Securities made a headline-grabbing move by upping its stake in Lockheed Martin by 88,614.3% in Q1. The firm acquired ...
Regeneron Pharmaceuticals just hit a new 52-week low after UBS dropped its price target and slapped on a neutral rating.
Bristol Myers and BioNTech are teaming up to develop and commercialize BNT327, a cancer therapy with blockbuster ambition.
Senate Republicans are eyeing Medicare Advantage cuts to bankroll Trump-era tax plans, potentially squeezing private insurers ...
Gradient Investments increased its Starbucks stake by purchasing 17,700 more shares in Q1, bringing their total to 345,979 ...
RBC Capital maintained its "Sector Perform" rating for Automatic Data Processing, keeping the price target steady at $315.
Annex Advisory Services increased its holdings in Marsh & McLennan Companies by 2.1%, adding 1,288 shares for a total stake ...
Boston Scientific might not scream “buy me now,” but it’s quietly flaunting strong growth credentials. The company holds a ...
McLean Asset Management has tossed its investment hat into the pharmacy aisle, buying over 5,000 shares of CVS Health worth ...
Mondelez International saw a tasty 23.6% jump in its stake held by Thurston Springer Miller Herd & Titak Inc. this quarter.